Ads
related to: rituximab for multifocal motor neuropathy treatment guidelines 2022 pdf- IKEMA Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- IKEMA Patient Profile
Potential SARCLISA Candidates
See Who May Be Appropriate
- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Contact a Representative
For Questions and Information
About SARCLISA
- IKEMA Trial
Search results
Results From The WOW.Com Content Network
Multifocal motor neuropathy (MMN) is a progressively worsening condition where muscles in the extremities gradually weaken. The disorder, a pure motor neuropathy syndrome, is sometimes mistaken for amyotrophic lateral sclerosis (ALS) because of the similarity in the clinical picture, especially if muscle fasciculations are present.
Inflammatory demyelinating diseases (IDDs), sometimes called Idiopathic (IIDDs) due to the unknown etiology of some of them, are a heterogenous group of demyelinating diseases - conditions that cause damage to myelin, the protective sheath of nerve fibers - that occur against the background of an acute or chronic inflammatory process.
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...
Acute motor axonal neuropathy: Peripheral nerves: Anti-GM1: Confirmed Part of Guillain-Barré syndrome prevalence [54] Anti-NMDA receptor encephalitis: Brain: Anti-NMDA receptor: Confirmed 1.5 per million [55] Autoimmune encephalitis: Brain Various, depending on subtype (e.g., NMDA receptor antibodies, LGI1 antibodies) Confirmed Rare [56] Balo ...
In the treatment of polyneuropathies one must ascertain and manage the cause, among management activities are: weight decrease, use of a walking aid, and occupational therapist assistance. Additionally, BP control in those with diabetes is helpful, while intravenous immunoglobulin is used for multifocal motor neuropathy.
Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).